Abiopharma

New Form 424B2 - BANK OF NOVA SCOTIA <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001839882-26-039761 <b>Size:</b> 702 KB

Clearmind Advances CMND-100 to Alcohol Use Disorder Patients After Achieving Primary Safety Endpoint

(19% Negative) INTUITIVE MACHINES, INC. (LUNR) Reports Q3 2026 Financial Results

Financial Statements and Related Announcement: Half Yearly Results

Interested Person Transaction: Interested Person Transaction pursuant to Catalist Rule 905(2)

(99% Neutral) ADVANCED FLOWER CAPITAL INC. (AFCG) Reports Q3 2026 Financial Results

New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001839882-26-039760 <b>Size:</b> 674 KB

New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001839882-26-039759 <b>Size:</b> 355 KB

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0000950103-26-012292 <b>Size:</b> 189 KB

New Form N-PX - HORIZON BANCORP INC /IN/ <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001438934-26-000729 <b>Size:</b> 80 KB

AFC Announces Financial Results for the Second Quarter 2026

IREN Delivers Horizon 1 to Microsoft and Achieves NVIDIA Exemplar Cloud Status on GB300 NVL72

New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001839882-26-039758 <b>Size:</b> 393 KB

New Form 424B2 - BANK OF NOVA SCOTIA <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001839882-26-039757 <b>Size:</b> 663 KB

Karyopharm Reports Second Quarter 2026 Financial Results and Highlights Continued Progress Toward Myelofibrosis sNDA Submission